PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pancreatic cancer drug trial stopped early
Disease control TerminatedThis early-stage study tested a new drug called BI 765883, given alone or with chemotherapy, for people with advanced pancreatic cancer that had spread or returned. The goal was to find a safe dose and see if it could shrink tumors. The study was terminated early after enrolling …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 01, 2026 15:40 UTC
-
New radiation therapy targets Hard-to-Treat cancers in early trial
Disease control TerminatedThis early-phase study tested a new drug called 177Lu-FF58, which delivers radiation directly to cancer cells. It was for people with advanced pancreatic, stomach, or brain cancer that had not responded to other treatments. The main goal was to check the drug's safety and find th…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
Promising cancer drug study halted early
Disease control TerminatedThis study tested a drug called Promitil in people with ovarian or pancreatic cancer that had specific gene mutations (BRCA or related). The goal was to see if the drug could control the cancer after first treatment stopped working. The study was stopped early, so results are lim…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
Depression drug studied for pancreatic cancer patients – trial cut short
Symptom relief TerminatedThis study tested whether the antidepressant escitalopram could reduce depression in people with localized pancreatic cancer who were receiving chemotherapy before surgery. Only 4 participants were enrolled before the trial was stopped early. The goal was to see if the drug impro…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 15:38 UTC